Lung Cancer
Collection
Collection
- ISSN: 01695002
Published by Elsevier Ireland Ltd
-
Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial Article
Lung Cancer, 150-153.B.J. Slotman (Ben), C. Faivre-Finn (Corinne), H. van Tinteren (Harm), A. Keijser (Astrid), J. Praag (John), J.L. Knegjens (Joost L.), M. Hatton (Matthew), van Dam, I. (Iris), A.H.D. van der Leest, B. Reymen (Bart), et al. Stigt, J. (Jos), Haslett, K. (Kate), Tripathi, D. (Devashish), E.F. Smit (Egbert) and S. Senan (Suresh)
June 2017
-
Quantification of growth patterns of screen-detected lung cancers: The NELSON study Article
Lung Cancer, 48-54.M.A. Heuvelmans (Marjolein), R. Vliegenthart (Rozemarijn), H.J. de Koning (Harry), H.J.M. Groen (Henk), van Putten, M.J.A.M. (Michel J.A.M.), A.U. Yousaf-Khan (Uraujh), C. Weenink (Carla), K. Nackaerts (Kristiaan), P.A. de Jong (Pim) and M. Oudkerk (Matthijs)
June 2017
-
The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features Article
Lung Cancer, 128-136.A.D. Herrera-Martínez (Aura), Gahete, M.D. (Manuel D.), Sánchez-Sánchez, R. (Rafael), Salas, R.O. (Rosa Ortega), Serrano-Blanch, R. (Raquel), Salvatierra, Á. (Ángel), L.J. Hofland (Leo), Luque, R.M. (Raúl M.), M.A. Gálvez Moreno (María Angeles) and J.P. Castaño (Justo)
July 2017 -
Uniform and blinded cause of death verification of the NELSON lung cancer screening participants Article
Lung Cancer, 131-134.A.U. Yousaf-Khan (Uraujh), C.M. van der Aalst (Carlijn), J.G.J.V. Aerts (Joachim), M.A. den Bakker (Michael) and H.J. de Koning (Harry)
September 2017 -
Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study Article
Lung Cancer, 45-50.M.A. Heuvelmans (Marjolein), Walter, J.E. (Joan E), Peters, R.B. (Robin B), Bock, G.H.D. (Geertruida H de), A.U. Yousaf-Khan (Uraujh), Aalst, C.M.V.D. (Carlijn M van der), H.J.M. Groen (Henk), K. Nackaerts (Kristiaan), Ooijen, P.M.V. (Peter MA van), Koning, H.J.D. (Harry J de), et al. M. Oudkerk (Matthijs) and R. Vliegenthart (Rozemarijn)
November 2017
-
Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking—A modelling study Article
Lung Cancer, 61-69.Y. Tomonaga (Yuki), K. ten Haaf (Kevin), T. Frauenfelder (Thomas), M. Kohler (Malcolm), R.D. Kouyos (Roger), M. Shilaih (Mohaned), M. Lorez (Matthias), H.J. de Koning (Harry), M. Schwenkglenks (Matthias) and M.A. Puhan (Milo A.)
July 2018 -
Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study Article
Lung Cancer, 103-108.Walter, J.E. (Joan E.), M.A. Heuvelmans (Marjolein), G.H. de Bock (Geertruida), A.U. Yousaf-Khan (Uraujh), H.J.M. Groen (Henk), C.M. van der Aalst (Carlijn), K. Nackaerts (Kristiaan), P.M.A. van Ooijen (Peter), H.J. de Koning (Harry), R. Vliegenthart (Rozemarijn), et al. M. Oudkerk (Matthijs)
November 2018
-
Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter? Article
Lung CancerGiaj-Levra, N. (Niccolò), Giaj Levra, M. (Matteo), Berghmans, T. (Thierry), Novello, S. (Silvia), Hendriks, L.E. (Lizza E.), Levy, A. (Antonin), Besse, B. (Benjamin) and Dingemans, A.-M.C. (Anne-Marie C.)
January 2019